Cargando…
An open-label study of the tolerability and potential efficacy of memantine for treating refractory chronic cough
Blocking NMDA receptors with memantine in refractory chronic cough patients is poorly tolerated and demonstrates no improvement in cough https://bit.ly/3kgx2g1
Autores principales: | Abdulqawi, Rayid, Satia, Imran, Holt, Kimberley J., Dockry, Rachel, Sen, Shilpi, Smith, Jaclyn A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450582/ https://www.ncbi.nlm.nih.gov/pubmed/34549048 http://dx.doi.org/10.1183/23120541.00447-2021 |
Ejemplares similares
-
A double-blind randomised placebo-controlled trial investigating the effects of lesogaberan on the objective cough frequency and capsaicin-evoked coughs in patients with refractory chronic cough
por: Badri, Huda, et al.
Publicado: (2022) -
Assessing cough symptom severity in refractory or unexplained chronic cough: findings from patient focus groups and an international expert panel
por: Kum, Elena, et al.
Publicado: (2022) -
Cough rhythms in asthma: Potential implication for management
por: Lodhi, Sirat, et al.
Publicado: (2019) -
Chronic cough is associated with increased reporting of autonomic symptoms
por: Dockry, Rachel J., et al.
Publicado: (2021) -
Cough symptom severity in patients with refractory or unexplained chronic cough: a systematic survey and conceptual framework
por: Kum, Elena, et al.
Publicado: (2021)